Literature DB >> 7498230

Iodine-131 Hippuran for the estimation of renal plasma flow: requirements for radiochemical purity.

R A Kengen1, S Meijer, A K van Zanten, H Beekhuis, J G Kosterink, D Albertus Piers.   

Abstract

For many years iodide-131 Hippuran has been used as a tracer to measure effective renal plasma flow (ERPF). Because of the low renal clearance of free 131I-iodide and the inability to count it separately from 131I-Hippuran, free 131I-iodide will lower the calculated 131I-Hippuran clearance, resulting in a lower estimated ER-PF. This study was performed to establish the maximum allowable radiochemical impurity of free 131I-iodide in 131I-Hippuran preparations for ERPF measurements in continuous clearance studies. A known amount of 123I-iodide was added to the (131I-iodide-free) 131I-Hippuran solution used for continuous infusion clearance studies in nine patients. 123I-iodide activity was used because it can be counted separately from 131I-Hippuran in the infusion solutions and plasma samples while it behaves exactly like 131I-iodide, so that the results obtained with 123I-iodide can be extrapolated to 131I-iodide. After performing the clearance studies, the ERPF was calculated firstly with 131I-Hippuran activity only (= true ERPF) and secondly including the free radioactive iodide activity (= false ERPF) in the clearance formula. As expected, if free 131I-iodide is present in the infusion solution, its concentration in plasma will be highest at the end of the clearance study. The 131I-iodide concentration in plasma relative to the 131I-Hippuran concentration will be higher in patients with high ERPF values.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7498230     DOI: 10.1007/bf01254570

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  9 in total

1.  Evaluation of radioiodinated hipuran for the estimation of renal plasma flow.

Authors:  M K BURBANK; W N TAUXE; F T MAHER; J C HUNT
Journal:  Proc Staff Meet Mayo Clin       Date:  1961-07-19

Review 2.  Procedures of choice in renal nuclear medicine.

Authors:  M D Blaufox
Journal:  J Nucl Med       Date:  1991-06       Impact factor: 10.057

3.  A simplified clinical procedure for measurement of glomerular filtration rate and renal plasma flow.

Authors:  D P EARLE; R W BERLINER
Journal:  Proc Soc Exp Biol Med       Date:  1946-06

Review 4.  Measurement of renal function with radionuclides.

Authors:  C D Russell; E V Dubovsky
Journal:  J Nucl Med       Date:  1989-12       Impact factor: 10.057

Review 5.  Quantification of renal haemodynamics with radionuclides.

Authors:  A M Peters
Journal:  Eur J Nucl Med       Date:  1991

6.  A radioisotope method for simultaneous determination of the glomerular filtration rate and the effective renal plasma flow.

Authors:  A J Donker; G K van der Hem; W J Sluiter; H Beekhuis
Journal:  Neth J Med       Date:  1977       Impact factor: 1.422

7.  Pharmacokinetics of technetium-99m-MAG3 in humans.

Authors:  B Bubeck; W Brandau; E Weber; T Kälble; N Parekh; P Georgi
Journal:  J Nucl Med       Date:  1990-08       Impact factor: 10.057

8.  Measurement of effective renal plasma flow: a comparison of methods.

Authors:  E J Fine; M Axelrod; J Gorkin; K Saleemi; M D Blaufox
Journal:  J Nucl Med       Date:  1987-09       Impact factor: 10.057

Review 9.  Renal radiopharmaceuticals--an update.

Authors:  L R Chervu; M D Blaufox
Journal:  Semin Nucl Med       Date:  1982-07       Impact factor: 4.446

  9 in total
  1 in total

1.  Simple purification and quality control of radio-iodinated Hippuran for the estimation of effective renal plasma flow.

Authors:  J G Kosterink; J H Boorsma; E J Franssen; R A Kengen
Journal:  Eur J Nucl Med       Date:  1995-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.